The Angiogenesis Foundation

The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The founders were former students of Dr. Judah Folkman, a pioneer of angiogenesis research.

The Angiogenesis Foundation
Type
Non-profit
Founded1994 in Cambridge, MA
FounderWilliam W. Li, MD
HeadquartersCambridge, MA, U.S.
Revenue1,772,286 US dollar (2017) 
Websiteangio.org

The foundation focuses on treatments in the areas of cancer, cardiology, wound healing, dermatology, and ophthalmology.

The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply.[1]

In 1998, the Foundation led the establishment of angiogenic growth factor therapy as the first advanced treatment for diabetic foot ulcers. In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer,[2] and later broadening to breast, lung, liver, kidney, and brain cancers.

References
  1. Dog's tale of survival opens door in cancer research, July 24, 2002
  2. Colon cancer drug seen as long awaited victory, February 26, 2004
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.